StrainsforPains logo

StrainsforPains(OTC) EBYH

Market Cap$3.20MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1999)-100%
5 Year+8%
1 Year+55%
1 Month+18%
$0.25
+12.68%
+0.03Today
StrainsforPains last closing stock price
MetricPriceDate
Last closeUSD 0.252026-10-15
StrainsforPains stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+7.29%USD 0.232026-10-08
1 month+18.1%USD 0.212026-09-15
3 month+37.78%USD 0.182026-07-10
Year to date+54.52%USD 0.162025-12-18
1 year+54.52%USD 0.162025-10-14
3 year+24.75%USD 0.202023-10-16
5 year+7.83%USD 0.232021-10-15
Since inception-100%USD 4,980.471999-06-08

StrainsforPains Financials at a Glance

Market Cap

$3.20MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$40.09K

Net Income (TTM)

-$157.40K

EPS (TTM)

-$0.01

P/E Ratio

-22.96

Dividend

$0.00

Beta (Volatility)

0.04 (Low)

Price

$0.25

Volume

2,010

Open

$0.25

Previous Close

$0.25

Daily Range

$0.25 - $0.25

52-Week Range

$0.16 - $0.25

Estimated Earnings Date

N/A

EBYH News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About StrainsforPains

StrainsforPains, Inc. operates as a health and wellness company specializing in data technology for CBD and THC products. The company provides a medical marijuana recommendation engine through an app, assisting patients and healthcare professionals in assessing cannabis strains for various ailments.

Products and Services
  • Medical marijuana recommendation engine app
  • CBD creams for pain relief
  • Products targeting muscle pain and migraines
Growth Outlook
  • Market demand for CBD products continues to rise
  • Expansion into new therapeutic areas planned
  • Increased partnerships with healthcare providers expected
Financial Highlights
  • Recent quarterly revenue of 2,912, showing potential for growth
  • Trailing twelve months (TTM) revenue of 29,565 indicates a steady increase
  • Current ratio of 7.72 suggests strong liquidity position
StrainsforPains, Inc. is positioned in a rapidly growing sector, with increasing consumer interest in health and wellness products. The company's innovative approach to integrating technology with cannabis products offers a unique value proposition. Recent financial data indicates a potential for revenue growth, supported by a strong liquidity position. The focus on expanding product offerings and partnerships within the healthcare sector may further enhance growth opportunities. Investors may find the company's strategic direction and market positioning appealing as the demand for cannabis-related health solutions continues to evolve.
AI Generated • Oct 10, 2026

Industry

Health Care Technology

Sector

Health Care

CEO

Yehoshua Simon Shainberg

Website

www.strainsforpains.com

Headquarters

New York City, NY 10013, US

EBYH Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

-101.85%

Net Income Margin

-392.68%

Return on Equity

14.02%

Return on Capital

-4.94%

Return on Assets

-9.08%

Earnings Yield

-4.36%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.20MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

12.92M

Volume

2.01K

Avg. Volume

2.13K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$40.83K

EBITDA

-$40.83K

Operating Cash Flow

-$188.91K

Capital Expenditure

$1.80

Free Cash Flow

-$188.91K

Cash & ST Invst.

$3.62K

Total Debt

$1.96M

StrainsforPains Performance Analysis

StrainsforPains annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 7,393-18.8%
20232023-12-31USD 84,1171037.8%
20242024-12-31USD 180,228114.3%
20252025-12-31USD 40,191-77.7%
StrainsforPains sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30125.4%
Q32025-09-30276.0%
Q42025-12-31-81.2%
Q22026-06-30N/A
StrainsforPains annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.02-15.2%
20232023-12-31USD -0.01-24.3%
20242024-12-31USD -0.00-83.2%
20252025-12-31USD -0.01386.4%
StrainsforPains sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-303.1%
Q32025-09-3061.3%
Q42025-12-31-166.7%
Q22026-06-30N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$2.91K

-3.5%

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$3.20MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

0

N/A

Net Income

-$46.89K

+0.1%

EBITDA

-$17.75K

+0.2%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$3.62K

+3344.3%

Total Debt

$1.96M

+0.0%

Accounts Receivable

$225.00K

+0.0%

Inventory

$0.00

N/A

Long Term Debt

$1.96M

+0.0%

Short Term Debt

$0.00

N/A

Return on Assets

-9.08%

N/A

Return on Invested Capital

-2.40%

N/A

Free Cash Flow

-$41.85K

+41.2%

Operating Cash Flow

-$41.85K

+41.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HESGHealth Sciences Group, Inc.
$0.00+0.00%
MITIMitesco, Inc.
$0.04+38.69%
CSOCCaduceus Software Systems Corp.
$0.00+0.00%
KAYSKaya Holdings, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
CRWVCoreWeave
$60.72-1.09%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$99.10+5.79%
INTCIntel
$92.46+2.90%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$46.39-5.77%

Questions About EBYH

What is the current price of StrainsforPains?

StrainsforPains is trading at $0.25 per share.

What is the 52-week range for StrainsforPains?

Over the past 52 weeks, StrainsforPains has traded between $0.16 and $0.25.

How much debt does StrainsforPains have?

As of the most recent reporting period, StrainsforPains reported total debt of $1.96M.

How much cash does StrainsforPains have on hand?

StrainsforPains reported $3.62K in cash and cash equivalents in its most recent financial results.

What is StrainsforPains’s dividend yield?

StrainsforPains does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services